It is speculated that ovarian cancer cells promote the expression of CCL28 on the cell surface through the HIF signaling pathway during hypoxia, and CCL28 interacts with CCR10 on the surface of Tregs to recruit it by chemotaxis into the tumor tissue and exert immunosuppressive effects [94]. This evidence concerns the gene CCL28 and ovarian carcinoma.